254
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Formulation of chitosan coated nanoliposomes for the oral delivery of colistin sulfate: in vitro characterization, 99mTc-radiolabeling and in vivo biodistribution studies

ORCID Icon, &
Pages 626-635 | Received 19 Aug 2020, Accepted 19 Feb 2021, Published online: 09 Apr 2021

References

  • Mauro N, Schillaci D, Varvarà P, et al. Branched high molecular weight glycopolypeptide with broad-spectrum antimicrobial activity for the treatment of biofilm related infections. ACS Appl Mater Interfaces. 2018;10(1):318–331.
  • Michalopoulos A, Tsiodras S, Rellos K, et al. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005;11(2):115–121.
  • Tewes F, Brillault J, Gregoire N, et al. Comparison between colistin sulfate dry powder and solution for pulmonary delivery. Pharmaceutics. 2020;12(6):557.
  • Dubashynskaya NV, Skorik YA. Polymyxin delivery systems: recent advances and challenges. Pharmaceuticals. 2020;13(5):83.
  • Loho T, Dharmayanti A. Colistin: an antibiotic and its role in multiresistant Gram-negative infections. Acta Medica Indonesiana. 2015;47(2):157–168.
  • Michalopoulos AS, Karatza DC, Gregorakos L. Pharmacokinetic evaluation of colistin sodium. Expert Opin Drug Metab Toxicol. 2011;7(2):245–255.
  • Schwartz BS. The polypeptides of the polymyxin group. Expert Chemother. 1964;3:217.
  • Michalopoulos A, Falagas ME. Colistin and polymyxin B in critical care. Crit Care Clin. 2008;24(2):377–391.
  • Kwa A, Kasiakou SK, Tam VH, et al. Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti-Infective Ther. 2007;5(5):811–821.
  • Orwa J, Govaerts C, Gevers K, et al. Study of the stability of polymyxins B1, E1 and E2 in aqueous solution using liquid chromatography and mass spectrometry. J Pharm Biomed Anal. 2002;29(1–2):203–212.
  • Elkhoury K, Russell CS, Sanchez‐Gonzalez L, et al. Soft‐Nanoparticle Functionalization of Natural Hydrogels for tissue engineering applications. Adv Healthcare Mater. 2019;8(18):1900506.
  • Takahashi M, Inafuku K-i, Miyagi T, et al. Efficient preparation of liposomes encapsulating food materials using lecithins by a mechanochemical method. J Oleo Sci. 2007;56(1):35–42.
  • Hasan M, Elkhoury K, Belhaj N, et al. Growth-inhibitory effect of chitosan-coated liposomes encapsulating curcumin on MCF-7 breast cancer cells. Mar Drugs. 2020;18(4):217.
  • Brandl M. Liposomes as drug carriers: a technological approach. Biotechnol Annu Rev. 2001;7:59–85.
  • Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discovery. 2005;4(2):145–160.
  • He H, Lu Y, Qi J, et al. Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin. Acta Pharmaceutica Sinica B. 2018;8(1):97–105.
  • Xing H, Hwang K, Lu Y. Recent developments of liposomes as nanocarriers for theranostic applications. Theranostics. 2016;6(9):1336.
  • Takeuchi H, Matsui Y, Yamamoto H, et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Controlled Release. 2003;86(2–3):235–242.
  • Chen W, Fan D, Meng L, et al. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats. Drug Dev Ind Pharm. 2012;38(1):104–110.
  • Thongborisute J, Tsuruta A, Kawabata Y, et al. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. J Drug Targeting. 2006;14(3):147–154.
  • Sugihara H, Yamamoto H, Kawashima Y, et al. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin. J Liposome Res. 2012;22(1):72–79.
  • Chen D, Xia D, Li X, et al. Comparative study of Pluronic® F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Int J Pharm. 2013;449(1–2):1–9.
  • Han H-K, Shin H-J, Ha DH. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci. 2012;46(5):500–507.
  • Karn PR, Vanić Z, Pepić I, et al. Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev Ind Pharm. 2011;37(4):482–488.
  • Vural I, Sarisozen C, Olmez SS. Chitosan coated furosemide liposomes for improved bioavailability. J Biomed Nanotechnol. 2011;7(3):426–430.
  • Miyoshi S, Mitsuoka K, Nishimura S, et al. Radioisotopes in drug research and development: focus on positron emission tomography. In: Singh N, editor. Radioisotopes-applications in bio-medical science. 1st ed. London (UK): InTech; 2011. p. 93–114.
  • Krauser JA. A perspective on tritium versus carbon-14: ensuring optimal label selection in pharmaceutical research and development [Comparative Study]. J Labelled Comp Radiopharm. 2013;56(9–10):441–446.
  • Dash A, Knapp FR, Pillai M. 99Mo/99mTc separation: an assessment of technology options. Nucl Med Biol. 2013;40(2):167–176.
  • Faintuch BL, Pereira NPS, Faintuch S, et al. Lanreotide and octreotide complexed with technetium-99m: labeling, stability and biodistribution studies. Rev Bras Cienc Farm. 2004;40(1):101–110.
  • Wang S, Yu S, Lin Y, et al. Co-delivery of ciprofloxacin and colistin in liposomal formulations with enhanced in vitro antimicrobial activities against multidrug resistant Pseudomonas aeruginosa. Pharm Res. 2018;35(10):187.
  • Yu S, Wang S, Zou P, et al. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections. Int J Pharm. 2020;575:118915.
  • Liu Y-H, Kuo S-C, Yao B-Y, et al. Colistin nanoparticle assembly by coacervate complexation with polyanionic peptides for treating drug-resistant gram-negative bacteria. Acta Biomater. 2018;82:133–142.
  • Nguyen TX, Huang L, Liu L, et al. Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride. J Mater Chem B. 2014;2(41):7149–7159.
  • Sağıroğlu AA. Chitosan-coated liposome containing carbamazepine and coenzyme Q10: design, optimization and evaluation. J Liposome Res. 2020;26:1–20.
  • Lee C-M, Kim D-W, Lee K-Y. Effects of chitosan coating for liposomes as an oral carrier. J Exp Biomed Sci. 2011;17(3):211–216.
  • Guo J-x, Ping Q-n, Jiang G, et al. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm. 2003;260(2):167–173.
  • Qumbar M, Imam SS, Ali J, et al. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. Biomed Pharmacother. 2017;93:255–266.
  • Kozhikhova KV, Ivantsova MN, Tokareva MI, et al. Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin. Pharm Dev Technol. 2018;23(4):334–342.
  • Hasan M, Elkhoury K, Kahn CJ, et al. Preparation, characterization, and release kinetics of chitosan-coated nanoliposomes encapsulating curcumin in simulated environments. Molecules. 2019;24(10):2023.
  • Patel A, Ray S, Thakur R. In vitro evaluation and optimization of controlled release floating drug delivery system of metformin hydrochloride. DARU J Pharma Sci. 2006;14(2):57–64.
  • Hopkins E, Sharma S. Physiology, acid base balance. Treasure Island (FL): StatPearls Publishing; 2019.
  • Alsarra IA. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. J Microencapsul. 2009;26(3):272–278.
  • Ammar H, Ghorab M, El-Nahhas S, et al. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm. 2011;405(1–2):142–152.
  • Aboumanei MH, Abdelbary AA, Ibrahim IT, et al. Improved targeting and tumor retention of a newly synthesized antineoplaston A10 derivative by intratumoral administration: molecular docking, technetium 99m radiolabeling, and in vivo biodistribution studies. Cancer Biother Radiopharm. 2018;33(6):221–232.
  • Sanad M. Labeling and biological evaluation of 99m Tc-azithromycin for infective inflammation diagnosis. Radiochemistry. 2013;55(5):539–544.
  • Motaleb M, El-Tawoosy M, Mohamed S, et al. 99mTc-labeled teicoplanin and its biological evaluation in experimental animals for detection of bacterial infection. Radiochemistry. 2014;56(5):544–549.
  • Hohlbaum K, Bert B, Dietze S, et al. Impact of repeated anesthesia with ketamine and xylazine on the well-being of C57BL/6JRj mice. PLoS One. 2018;13(9):e0203559.
  • Rashed H, Ibrahim I, Motaleb M, et al. Preparation of radioiodinated ritodrine as a potential agent for lung imaging. J Radioanal Nucl Chem. 2014;300(3):1227–1233.
  • Abd El-Karim SS, Anwar MM, Syam YM, et al. Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies. Bioorg Chem. 2018;81:481–493.
  • Motaleb M, Adli A, El‐Tawoosy M, et al. An easy and effective method for synthesis and radiolabelling of risedronate as a model for bone imaging. J Labelled Compd Radiopharm. 2016;59(4):157–163.
  • Akbari V, Abedi D, Pardakhty A, et al. Release studies on ciprofloxacin loaded non-ionic surfactant vesicles. Avicenna J Med Biotechnol. 2015;7(2):69.
  • Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105(1):1–6.
  • Aboumanei MH, Mahmoud AF. Design and development of a proniosomal transdermal drug delivery system of caffeine for management of migraine: in vitro characterization, 131I-radiolabeling and in vivo biodistribution studies. Process Biochem. 2020;97:201–212.
  • Affandi M, Julianto T, Majeed A. Development and stability evaluation of astaxanthin nanoemulsion. Asian J Pharm Clin Res. 2011;4(1):142–148.
  • Shuwaili AHA, Rasool BKA, Abdulrasool AA. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm. 2016;102:101–114.
  • Arab Tehrany E, Kahn CJ, Baravian C, et al. Elaboration and characterization of nanoliposome made of soya; rapeseed and salmon lecithins: application to cell culture B Biointerfaces. Coll Surf B Biointerf. 2012;95:75–81.
  • Khalil M, Hashmi U, Riaz R, et al. Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: a potential topical treatment for posterior segment diseases. Int J Biol Macromol. 2020;143:483–491.
  • Jain NK, Chaurasia M, Jain S. Investigation of galactosylated low molecular weight chitosan-coated liposomes for cancer specific drug delivery. Trop J Pharm Res. 2014;13(5):661–668.
  • Bnyan R, Khan I, Ehtezazi T, et al. Surfactant effects on lipid-based vesicles properties. J Pharm Sci. 2018;107(5):1237–1246.
  • Hao Y, Zhao F, Li N, et al. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244(1–2):73–80.
  • Gupta M, Vaidya B, Mishra N, et al. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol. 2011;39(6):376–384.
  • Wang X, Gao Y. Effects of length and unsaturation of the alkyl chain on the hydrophobic binding of curcumin with Tween micelles. Food Chem. 2018;246:242–248.
  • Cipolla D, Gonda I, Chan H-K. Liposomal formulations for inhalation. Ther Deliv. 2013;4(8):1047–1072.
  • Alshraim MO, Sangi S, Harisa GI, et al. Chitosan-coated flexible liposomes magnify the anticancer activity and bioavailability of docetaxel: impact on composition. Molecules. 2019;24(2):250.
  • Bang S, Hwang I, Yu Y, et al. Application of the combined use of ultrasonic homogenization and electro-spraying in the formation of nano carrier systems. J Microencapsul. 2011;28(6):557–567.
  • Bang S, Hwang I, Yu Y, et al. Influence of chitosan coating on the liposomal surface on physicochemical properties and the release profile of nanocarrier systems. J Microencapsul. 2011;28(7):595–604.
  • Ibrahim IT, Elkolally MT, Abd Elgany IY, et al. Preparation of 99mTc-clomiphene citrate as a novel agent for breast cancer imaging. ISRN Oncol. 2012;2012:581281.
  • El-Ghany E, Amine A, El-Sayed A, et al. Radiochemical and biological characteristics of 99mTc-piroxicam for scintigraphy of inflammatory lesions. J Radioanal Nucl Chem. 2005;266(1):125–130.
  • Kalam MA, Alshamsan A, Aljuffali IA, et al. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv. 2016;23(3):896–907.
  • Sakr T, Moustapha M, Motaleb M. 99mTc-nebivolol as a novel heart imaging radiopharmaceutical for myocardial infarction assessment. J Radioanal Nucl Chem. 2013;295(2):1511–1516.
  • Ibrahim I, El-Kolaly M, Aboumanei M, et al. 125I labeling of clomiphene and biodistribution studies for possible use as a model in breast cancer imaging. Appl Radiat Isot. 2016;115:37–44.
  • Li H, Jiang Z, Han B, et al. Pharmacokinetics and biodegradation of chitosan in rats. J Ocean Univ China. 2015;14(5):897–904.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.